[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-9984":3,"doc-seo-9984":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},9984,13056703019662,"Evangeline","https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188",8,"Research & Report","US Food and Drug Administration's Model-Informed Drug Development Meeting Program: From Pilot to Pathway","Describes how the FDA’s Model-Informed Drug Development (MIDD) Paired Meeting Pilot Program under PDUFA VI was implemented from 2018–2022 and evolved into a durable regulatory engagement pathway. It summarizes pilot demand, selection and meeting metrics, and the use of Written Responses Only for suitable requests, alongside broad applicability across drug development phases and therapeutic areas.","cbCairPQj8LiOP7t","https://ap.wps.com/l/cbCairPQj8LiOP7t","pdf",2601616,15,1,4,"English","en","",1776362593,10,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":23,"slug":31,"title":13,"keywords":24,"description":14,"schema_data":32,"social_meta":66,"head_meta":69,"extra_data":71,"updated_unix":25},105,"us-food-and-drug-administrations-model-informed-drug-development-meeting-program-from-pilot-to-pathway",{"@graph":33,"@context":65},[34,50],{"@type":35,"itemListElement":36},"BreadcrumbList",[37,41,45,48],{"item":38,"name":39,"@type":40,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":42,"name":43,"@type":40,"position":44},"https://docshare.wps.com/document/","Document",2,{"item":46,"name":12,"@type":40,"position":47},"https://docshare.wps.com/document/research-report/",3,{"item":49,"name":13,"@type":40,"position":21},"https://docshare.wps.com/document/us-food-and-drug-administrations-model-informed-drug-development-meeting-program-from-pilot-to-pathway/9984/",{"url":49,"name":13,"@type":51,"author":52,"headline":13,"publisher":54,"fileFormat":57,"description":14,"dateModified":58,"datePublished":59,"encodingFormat":57,"isAccessibleForFree":60,"interactionStatistic":61},"DigitalDocument",{"name":9,"@type":53},"Person",{"url":38,"name":55,"@type":56},"DocShare","Organization","application/pdf","2026-06-02","2026-04-16",true,{"@type":62,"interactionType":63,"userInteractionCount":19},"InteractionCounter",{"@type":64},"ViewAction","https://schema.org",{"og:url":67,"og:type":68,"og:title":13,"og:site_name":55,"og:description":14},"https://docshare.wps.com/document/us-food-and-drug-administrations-model-informed-drug-development-meeting-program-from-pilot-to-pathway/9984","article",{"robots":70,"canonical":67},"index,follow",{"doc_id":7,"site_id":30}]